The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALTIMMUNE INC COM NEW 02155H200 7,717 783,407 SH   OTR 1 0 783,407 0
ANAPTYSBIO INC COM 032724106 68,162 2,628,678 SH   OTR 1 0 2,628,678 0
APTEVO THERAPEUTICS INC COM NEW 03835L207 39,477 1,760,000 SH   OTR 1 0 1,760,000 0
BCTG ACQUISITION CORP COM 05492W103 5,334 468,750 SH   OTR 1 0 468,750 0
CHEMOCENTRYX INC COM 16383L106 6,695 500,000 SH   OTR 1 0 500,000 0
COHERUS BIOSCIENCES INC COM 19249H103 8,990 650,000 SH   OTR 1 0 650,000 0
EQUILLIUM INC COM 29446K106 3,534 600,000 SH   OTR 1 0 600,000 0
HERON THERAPEUTICS INC COM 427746102 122,718 7,907,087 SH   OTR 1 0 7,907,087 0
ITEOS THERAPEUTICS INC COM 46565G104 5,628 219,396 SH   OTR 1 0 219,396 0
LA JOLLA PHARMACEUTICAL CO COM 503459604 43,011 10,049,224 SH   OTR 1 0 10,049,224 0
NEXTCURE INC COM 65343E108 2,409 300,000 SH   OTR 1 0 300,000 0
ODONATE THERAPEUTICS INC COM 676079106 54,146 15,514,566 SH   OTR 1 0 15,514,566 0
RELMADA THERAPEUTICS INC COM 75955J402 3,201 100,000 SH   OTR 1 0 100,000 0
REVIVA PHARMACEUTCLS HLDGS I COM 76152G100 5,832 1,200,000 SH   OTR 1 0 1,200,000 0
ROCKET PHARMACEUTICALS INC COM 77313F106 112,133 2,531,800 SH   OTR 1 0 2,531,800 0
VINCERX PHARMA INC COM NEW 92731L106 13,388 1,030,634 SH   OTR 1 0 1,030,634 0